RFCA
CELG

R&F Capital Advisors’s Celgene Corp CELG Stock Holding History

R&F Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.99M Buy
15,976
+7,187
+82% +$860K 0.51% 28
2016
Q4 		$1.02M Buy
+8,789
New +$979K 0.36% 70

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

R&F Capital Advisors's CELG Position: Q1 2017 in Review

R&F Capital Advisors increased its Celgene Corp (CELG) stake by 82% in Q1 2017, buying an estimated $860K and bringing the position to 15,976 shares worth $1.99M. The position accounts for 0.51% of the portfolio, ranked #28.

R&F Capital Advisors first reported a position in CELG in Q4 2016 and has held it in 2 quarters since. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • R&F Capital Advisors held 15,976 shares of Celgene Corp worth $1.99M as of Q1 2017.
  • R&F Capital Advisors bought 7,187 Celgene Corp shares in Q1 2017, an estimated $860K.
  • Celgene Corp made up 0.51% of R&F Capital Advisors's portfolio in Q1 2017, its #28 holding.
  • R&F Capital Advisors first reported a position in Celgene Corp in Q4 2016 and has held it in 2 quarters since.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.